TherapeuticsMD (TXMD) Total Liabilities (2010 - 2026)

TherapeuticsMD has reported Total Liabilities for 17 years, with the latest figure at $10.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 7.72% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (down 7.72% YoY), and the FY2025 full-year result was $10.8 million, down 5.87% from the prior year.
• Total Liabilities for Q1 2026 stood at $10.6 million, down from $10.8 million in the prior quarter.
• The five-year high for Total Liabilities was $274.0 million in Q1 2022, with the low at $10.6 million in Q1 2026.
• Historically, Total Liabilities has averaged $51.5 million across 5 years, with a median of $13.4 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities advanced 10.12% — and 2023, when it plunged 89.93%.
• TherapeuticsMD's Total Liabilities stood at $55.3 million in 2022, then tumbled by 74.65% to $14.0 million in 2023, then retreated by 18.33% to $11.5 million in 2024, then fell by 5.87% to $10.8 million in 2025, then declined by 1.6% to $10.6 million in 2026.
• The last three Total Liabilities figures came in at $10.6 million (Q1 2026), $10.8 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.